Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis

Clinical & Experimental Allergy 2026 Open access

Read full text
Authors: Ellen Tameeris, Suzie J. van den Berg, Arthur M. Bohnen, Patrick J. E. Bindels, Gijs Elshout
DOI: 10.1111/cea.70360
Cited by: 1
References: 5

Abstract

Summary Daily intranasal corticosteroids improved quality of life most in adolescents (12–18 years) with seasonal allergic rhinoconjunctivitis. Antihistamines showed greater quality‐of‐life improvement than intranasal corticosteroids in children (6–11 years).

Fields of Study & Subjects

Allergic Rhinitis and Sensitization Sinusitis and nasal conditions Asthma and respiratory diseases

Publication details

Journal / source
Clinical & Experimental Allergy
Publisher
Wiley
Volume
56
Issue
9
Pages
1137–1139
Publication date
3 June 2026
Language
EN